Multivariate analysis showed that inactive ALDH2 (HR 2.25; 95% CI 1.18–4.59) was a significant predictor of the development of metachronous esophageal SCC or head and neck SCC. This evidence concerns the gene ALDH2 and esophageal squamous cell carcinoma.